SLLN-15
Product Specifications
UNSPSC Description
SLLN-15 is an oral active, selective and potent enhancer of autophagy that activates cytostatic macroautophagy/autophagy in triple-negative breast cancer (TNBC)[1].
Target Antigen
Autophagy
Type
Reference compound
Related Pathways
Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SLLN-15.html
Solubility
10 mM in DMSO
Smiles
C12=NC(NC3=CC=C(N4CC[Se]CC4)C=C3)=NC(N[C@@H]5C[Se]CC5)=C1N=CN2
Molecular Weight
507.35
References & Citations
[1]Chang CH, et al. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. 2019 Mar 1:1-15.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125465/SLLN-15-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125465/
Clinical Information
No Development Reported
CAS Number
2403650-93-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
38317141 1x10<sup>6</sup> cells/1.0ml
RAB28 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details